Zobrazeno 1 - 1
of 1
pro vyhledávání: '"F Oluf Krautwald"'
Autor:
M D Wewer, L Arp, S Melek, F Oluf Krautwald, I Vind, G Pedersen, A M Nielsen, M Kiszka-Kanowitz, T Boysen, K Theede, I Nordgaard-Lassen, F Bendtsen, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i053-i054
Background Direct health care costs have shifted towards drug-related expenditures in patients with inflammatory bowel disease (IBD). Frequently, patients will have to switch to a second- or third-line biological therapy due to no response or loss of